Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00574756 · ClinicalTrials.gov registry record · NA
Effect of Ranolazine on Echocardiographic Indices of Diastolic Dysfunction
A NA study, sponsored by University of California, San Diego.
- Terminated
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT00574756 is a NA study that was terminated before completion, run by University of California, San Diego. The registered enrollment target is 14 participants.
The verdict
NCT00574756, a NA study, was terminated before completion, sponsored by University of California, San Diego.
- TERMINATED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of ranolazine, an FDA-approved medication for the treatment of angina, on heart function by using echocardiography.
Interventions
- DRUG ranolazine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2007-12 |
| Est. Completion | 2010-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00574756
The ClinicalTrials.gov registry entry for NCT00574756 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ranolazine is the first listed.
NCT00574756 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00574756 about?
NCT00574756 is a clinical study titled "Effect of Ranolazine on Echocardiographic Indices of Diastolic Dysfunction". The purpose of this study is to evaluate the effects of ranolazine, an FDA-approved medication for the treatment of angina, on heart function by using echocardiography.
What is the current status of trial NCT00574756?
This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2007-12. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00574756?
The interventions under investigation include: ranolazine (DRUG).
Who is sponsoring clinical trial NCT00574756?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.